[The validation of the use of acarid antigens in developing vaccinal-serum preparations for the prevention of tick-borne encephalitis].
Votiakov
V I
VI
Mishaeva
N P
NP
D000818:Animals; D000941:Antigens / Q000276:immunology*; D001096:Arachnid Vectors / Q000276:immunology*; D003870:Dermacentor / Q000276:immunology; D004675:Encephalitis, Tick-Borne / Q000517:prevention & control* / Q000635:transmission; D005247:Feeding Behavior; D006801:Humans; D007114:Immunization; D051379:Mice; D012463:Saliva / Q000276:immunology; D013987:Ticks / Q000276:immunology*; D014612:Vaccines / Q000276:immunology / Q000302:isolation & purification*; D015164:Vaccines, Inactivated / Q000276:immunology / Q000302:isolation & purification
D000941:Antigens; D014612:Vaccines; D015164:Vaccines, Inactivated
Obosnovanie ispol'zovaniia akaroantigenov v razrabotke vaktsino-syvorotochnykh preparatov dlia profilaktiki kleshchevogo éntsefalita.